A COMPARISON OF 3-FACTOR PROTHROMBIN COMPLEX CONCENTRATE PRODUCTS IN WARFARIN-ASSOCIATED ICH

被引：0
作者：
Tucker, Natalie [1 ]
Cook, Ryan [2 ]
Cave, Brandon [1 ]
Jones, Morgan [1 ]
机构：
[1] Methodist Univ Hosp, Memphis, TN USA
[2] Methodist Healthcare, Memphis, TN USA
来源：
CRITICAL CARE MEDICINE | 2020年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
979
引用
收藏
页数：1
相关论文
共 50 条
[21]   PROTHROMBIN COMPLEX CONCENTRATE USE IN WARFARIN-ASSOCIATED INTRACEREBRAL HEMORRHAGE IS NOT ASSOCIATED WITH HIGHER THROMBOEMBOLIC RISKS [J].
Chou, Sherry ;
Konigsberg, Rachael ;
Cai, Xuemei ;
Bresette, Linda ;
Henderson, Galen ;
Sorond, Farzaneh ;
Ropper, Allan ;
Feske, Steven .
CRITICAL CARE MEDICINE, 2009, 37 (12) :A421-A421
[22]   3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors [J].
Hays, William Blake ;
Billups, Kelsey ;
Nicholson, Jessica ;
Bailey, Abby M. ;
Gregory, Haili ;
Weeda, Erin R. ;
Weant, Kyle A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2025, 58 (02) :276-283
[23]   Comparative Thromboembolic Risk of 3-Factor Versus 4-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal [J].
Wagner, S. ;
Kaide, C. ;
Li, J. ;
Reichert, E. .
ANNALS OF EMERGENCY MEDICINE, 2019, 74 (04) :S120-S120
[24]   Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis [J].
David J. Margraf ;
Sarah J. Brown ;
Heather L. Blue ;
Tamara L. Bezdicek ;
Julian Wolfson ;
Scott A. Chapman .
BMC Emergency Medicine, 22
[25]   Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: Does it matter? [J].
Voils, Stacy A. ;
Baird, Brian .
THROMBOSIS RESEARCH, 2012, 130 (06) :833-840
[26]   Comparison of 3-factor versus 4-factor prothrombin complex concentrate for emergent warfarin reversal: a systematic review and meta-analysis [J].
Margraf, David J. ;
Brown, Sarah J. ;
Blue, Heather L. ;
Bezdicek, Tamara L. ;
Wolfson, Julian ;
Chapman, Scott A. .
BMC EMERGENCY MEDICINE, 2022, 22 (01)
[27]   Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage [J].
Daniel Fischer ;
Jeffrey Sorensen ;
Gabriel V. Fontaine .
Neurocritical Care, 2018, 28 :43-50
[28]   Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for the Emergent Management of Warfarin-Associated Intracranial Hemorrhage [J].
Fischer, Daniel ;
Sorensen, Jeffrey ;
Fontaine, Gabriel V. .
NEUROCRITICAL CARE, 2018, 28 (01) :43-50
[29]   RISK OF VENOUS THROMBOEMBOLISM AFTER RECEIVING PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN-ASSOCIATED INTRACRANIAL HEMORRHAGE [J].
Felton, Diana ;
Foley, Elizabeth M. ;
Traub, Stephen J. ;
Vodonos, Alina ;
Ganetsky, Michael .
JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (01) :1-6
[30]   Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage [J].
Cicci, Corey D. ;
Weiss, Ashley ;
Dang, Cathyyen ;
Stanton, Matthew ;
Feldman, Ryan .
PHARMACOTHERAPY, 2022, 42 (05) :366-374
12345